280 related articles for article (PubMed ID: 34903620)
21. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
Takeda A; Goolsby C; Yaseen NR
Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
[TBL] [Abstract][Full Text] [Related]
22. The pediatric leukemia oncoprotein NUP98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.
Mayotte N; Roy DC; Yao J; Kroon E; Sauvageau G
Blood; 2002 Dec; 100(12):4177-84. PubMed ID: 12393433
[TBL] [Abstract][Full Text] [Related]
24. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).
Fujino T; Suzuki A; Ito Y; Ohyashiki K; Hatano Y; Miura I; Nakamura T
Blood; 2002 Feb; 99(4):1428-33. PubMed ID: 11830496
[TBL] [Abstract][Full Text] [Related]
25. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
Gough SM; Slape CI; Aplan PD
Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.
Michmerhuizen NL; Klco JM; Mullighan CG
Blood; 2020 Nov; 136(20):2275-2289. PubMed ID: 32766874
[TBL] [Abstract][Full Text] [Related]
27. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
28. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
[TBL] [Abstract][Full Text] [Related]
29. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
30. Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation.
Quéré R; Karlsson G; Hertwig F; Rissler M; Lindqvist B; Fioretos T; Vandenberghe P; Slovak ML; Cammenga J; Karlsson S
Blood; 2011 Jun; 117(22):5918-30. PubMed ID: 21471525
[TBL] [Abstract][Full Text] [Related]
31. Nup98-homeodomain fusions interact with endogenous Nup98 during interphase and localize to kinetochores and chromosome arms during mitosis.
Xu S; Powers MA
Mol Biol Cell; 2010 May; 21(9):1585-96. PubMed ID: 20237156
[TBL] [Abstract][Full Text] [Related]
32. An Image Analysis Pipeline for Quantifying the Features of Fluorescently-Labeled Biomolecular Condensates in Cells.
Baggett DW; Medyukhina A; Tripathi S; Shirnekhi HK; Wu H; Pounds SB; Khairy K; Kriwacki R
Front Bioinform; 2022; 2():897238. PubMed ID: 36304323
[TBL] [Abstract][Full Text] [Related]
33. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
34. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
35. Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.
Yassin ER; Abdul-Nabi AM; Takeda A; Yaseen NR
Leukemia; 2010 May; 24(5):1001-11. PubMed ID: 20339440
[TBL] [Abstract][Full Text] [Related]
36. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
Pineault N; Abramovich C; Ohta H; Humphries RK
Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
[TBL] [Abstract][Full Text] [Related]
37. A cryptic translocation leading to NUP98-PHF23 fusion in AML.
Ning Y
Best Pract Res Clin Haematol; 2016 Dec; 29(4):320-323. PubMed ID: 27890253
[TBL] [Abstract][Full Text] [Related]
38. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
Reader JC; Leng Q; Rassool FV; Ning Y
Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
[TBL] [Abstract][Full Text] [Related]
39. Nup98 regulation of histone methylation promotes normal gene expression and may drive leukemogenesis.
Sump B; Brickner JH
Genes Dev; 2017 Nov; 31(22):2201-2203. PubMed ID: 29284709
[TBL] [Abstract][Full Text] [Related]
40. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]